Blood dyscarias

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Loading Image
Fig. 14.7 - Sickle cell disease (peripheral blood smear): (A) Low magnification - irreversibly sickled cells, target cells, anisocytosis, poikilocytosis. (B) High magnification - an irreversibly sickled cell at center.

II. WHITE CELL DISORDERS / NEOPLASTIC DISEASES

Leukemias and Lymphomas - Overview

White cell neoplasms are classified by:
  1. Cell of origin - myeloid vs. lymphoid lineage
  2. Clinical behavior - acute (immature blasts) vs. chronic (mature cells)
  3. Site of predominance - bone marrow/blood (leukemia) vs. lymph nodes/solid tissue (lymphoma)
Leukemia TypeCell of OriginKey Features
Acute Myeloid Leukemia (AML)Myeloid precursorsAuer rods, myeloperoxidase+, most common acute leukemia in adults
Acute Lymphoblastic Leukemia (ALL)Lymphoid precursorsMost common leukemia in children; TdT+; good prognosis in children
Chronic Myelogenous Leukemia (CML)Myeloid stem cellPhiladelphia chromosome t(9;22), BCR-ABL fusion; treated with imatinib
Chronic Lymphocytic Leukemia (CLL)Mature B cellsMost common leukemia in adults in Western world; smudge cells

Lymphomas

TypeKey Features
Hodgkin Lymphoma (HL)Reed-Sternberg cells ("owl-eye" bilobed nuclei); EBV association; bimodal age distribution
Non-Hodgkin Lymphoma (NHL)Heterogeneous group; follicular (indolent) vs. diffuse large B-cell (aggressive)
Multiple MyelomaPlasma cell dyscrasia; lytic bone lesions, Bence Jones protein, CRAB criteria
Burkitt Lymphomat(8;14) MYC translocation; "starry-sky" pattern; associated with EBV

Plasma Cell Dyscrasias

  • Multiple Myeloma: Clonal proliferation of plasma cells in bone marrow; produces monoclonal immunoglobulin (M-protein)
    • CRAB criteria: hyperCalcemia, Renal failure, Anemia, Bone lesions
    • Bence Jones proteinuria (free light chains in urine)
  • MGUS (Monoclonal Gammopathy of Undetermined Significance): Many patients have no serious underlying pathology, but a malignant plasma cell dyscrasia may eventually develop in some cases - Bradley and Daroff's Neurology in Clinical Practice

III. MYELOPROLIFERATIVE NEOPLASMS

These are clonal disorders of multipotent myeloid stem cells characterized by proliferation of one or more myeloid lineages:
DisorderKey Feature
Polycythemia Vera (PV)JAK2 mutation; increased RBCs (and often WBCs/platelets); hyperviscosity; risk of thrombosis
Essential Thrombocythemia (ET)JAK2 or CALR mutation; marked thrombocytosis; thrombosis and bleeding
Primary Myelofibrosis (PMF)JAK2/CALR mutation; marrow fibrosis; extramedullary hematopoiesis; tear-drop cells
CMLBCR-ABL (Philadelphia chromosome)

IV. PLATELET AND COAGULATION DISORDERS

Thrombocytopenias (Platelet Count <150,000/µL)

CauseExamples
Decreased productionAplastic anemia, leukemia infiltrating marrow, myelodysplastic syndrome
Increased destruction - immuneITP (Immune Thrombocytopenic Purpura)
Increased destruction - non-immuneTTP, HUS, DIC
SequestrationHypersplenism

Coagulation Disorders

DisorderMechanismLab Findings
Hemophilia AFactor VIII deficiency (X-linked)Prolonged aPTT, normal PT
Hemophilia BFactor IX deficiency (X-linked)Prolonged aPTT, normal PT
von Willebrand DiseasevWF deficiency/dysfunctionProlonged bleeding time + aPTT
DICWidespread activation of coagulationProlonged PT + aPTT, low fibrinogen, elevated D-dimers, thrombocytopenia
Vitamin K deficiencyDeficiency of factors II, VII, IX, XProlonged PT > aPTT

V. OTHER IMPORTANT BLOOD DYSCRASIAS

Aplastic Anemia

  • Destruction or suppression of multipotent myeloid stem cells -> pancytopenia (anemia + leukopenia + thrombocytopenia)
  • Causes: autoimmune (most common), radiation, benzene, chloramphenicol, drugs
  • Bone marrow: hypocellular ("empty marrow"), replaced by fat
  • Treatment: immunosuppression (anti-thymocyte globulin + cyclosporine) or allogeneic stem cell transplant

Myelodysplastic Syndromes (MDS)

  • Clonal stem cell disorder with ineffective hematopoiesis and peripheral cytopenias
  • Dysplastic changes in all three cell lines
  • Risk of transformation to AML (~30%)

VI. KEY CLINICAL CORRELATIONS

Drug-Induced Blood Dyscrasias

Several drugs are notorious for causing blood dyscrasias:
  • Clozapine (antipsychotic): Risk of life-threatening agranulocytosis/blood dyscrasia; requires mandatory CBC monitoring - Maudsley Prescribing Guidelines in Psychiatry
  • Sulfinpyrazone: Associated with increased frequency of blood dyscrasias (NSAID-like) - Firestein & Kelley's Textbook of Rheumatology
  • Chloramphenicol: Aplastic anemia
  • Carbamazepine, phenytoin: Agranulocytosis, aplastic anemia

Blood Dyscrasia Presenting as Purpura / Cutaneous Signs

  • Purpura on the skin implies an underlying blood dyscrasia (platelet/vascular problem) - Fitzpatrick's Dermatology
  • Jaundice with purpura suggests concurrent hepatic pathology with coagulopathy

Ocular Manifestations

  • Hyphema can result from blood dyscrasias or clotting disorders - Wills Eye Manual

Summary Table: Key Lab Findings in Blood Dyscrasias

ConditionHb/HctMCVWBCPlateletsReticulocytesSpecial Test
Iron deficiency anemiaLowLow (microcytic)NormalNormal/HighLowLow ferritin, low TIBC saturation
Megaloblastic anemiaLowHigh (macrocytic)Normal/LowNormal/LowLowLow B12/folate, hypersegmented neutrophils
Hemolytic anemiaLowNormalNormalNormalHigh+ Coombs, elevated LDH/bilirubin
Aplastic anemiaLowNormalLowLowLowHypocellular bone marrow biopsy
AML/ALLLowVariableVery high (blasts)LowLowBlasts >20% in marrow
CMLNormal/LowNormalVery high (mature cells)HighNormalPhiladelphia chromosome
Polycythemia veraHighNormalHighHighNormalJAK2 mutation
ITPNormalNormalNormalVery lowNormalAnti-platelet antibodies
DICLowNormalVariableLowVariableElevated D-dimers, low fibrinogen, prolonged PT+aPTT

Sources:
  • Robbins, Cotran & Kumar Pathologic Basis of Disease (primary classification and hematopathology)
  • Goldman-Cecil Medicine International Edition
  • Harrison's Principles of Internal Medicine 22E
  • Bradley and Daroff's Neurology in Clinical Practice (plasma cell dyscrasias)
  • Maudsley Prescribing Guidelines in Psychiatry (drug-induced dyscrasias)
  • Fitzpatrick's Dermatology (cutaneous signs)
  • Wills Eye Manual (ocular complications)
This is a shared conversation. Sign in to Orris to start your own chat.